Marys Medicine

Cards cardiology audit and registration data standards for percutaneous coronary intervention

Cardiology Audit and Registration Data Standards for Percutaneous Coronary Intervention
A Report of the CARDS Expert Committee on Percutaneous Coronary Intervention
Dr. Anselm K. Gitt Prof. Ricardo Seabra-Gomes Dr. Dr José María Hernández Dr. Declan Sugrue Prof. Ciro Indolfi Prof. Jan G.P. Tijssen Prof. Eric Van Belle The CARDS Co-ordination Committee: Maarten L. Simoons (Chair), Prof. Francisco F. Avilés, Dr. Eric Boersma, Dr. Roger Boyle, Ms. Christine Brennan, Dr.
Francisco G. Cosío, Ms. Rachel Flynn, Prof. Kim Fox, Dr. Anselm K. Gitt, Dr. José María Hernández, Dr. Peter Kearney, Dr. Aldo Maggioni, Dr. Emer Shelley,Prof. Lars Wallentin.
CARDS PCI Expert Committee PCI Data Standards

CARDS PCI Expert Committee PCI Data Standards During Ireland's Presidency of the European Union (EU) (January to June 2004), the Department of Health and Children in Ireland worked with the EuropeanSociety of Cardiology, the Irish Cardiac Society and the European Commission to develop data standards for use in clinical cardiology. The Cardiology Audit and Registration Data Standards (CARDS) Project aimed to agree data standards for three modules of cardiovascular health information systems, viz. - acute coronary syndromes (ACS), percutaneous coronary interventions (PCI), and clinical electrophysiology (EP) (pacemakers, implantable cardioverterdefibrillators and ablation procedures).
A Coordination Committee and three multidisciplinary Expert Committees were established to develop the data standards, for use throughout the Europe, for each of the three modules. All existing databases, registries and surveys data sets were obtained, scrutinised very carefully and compiled into one largematrix for each of the modules. The main objective of each of the Expert Committees was to produce standardised data sets limited to less than 100variables. The variables derived had to reflect current treatment guidelines, and also were to be of use for clinical audit, clinical care of patients, serviceplanning and epidemiology. The process involved regular meetings of the Expert Committees, electronic communication between members, and consultationwith specialist groups and cardiac societies represented by the European Society of Cardiology. The development of the draft data standards for the threemodules was completed in April 2004.
These draft data standards were reviewed, discussed and formally adopted at a conference involving EU Member States in Cork, Ireland, in May 2004.
Members of the Expert Committees have carried out pilot tests within their own institutions to test the clarity and feasibility of using the data standards. Thedata standards and accompanying descriptive information will be disseminated to stakeholders throughout Europe from September to December 2004. TheEuropean Society of Cardiology will act as steward in this initiative.

CARDS PCI Expert Committee PCI Data Standards Description Document on PCI Data Standards
PCI Data Standards with appendices
Appendix 1
European Society of Cardiology /American College of Cardiology Definition of Myocardial Infarction
Appendix 2
Classification of data format
Appendix 3
Screen shot of PCI table
Appendix 4
Diagram of Coronary Arteries
Members of the CARDS PCI expert committee

CARDS PCI Expert Committee PCI Data Standards Table of Contents
1.1 Description of PCI Data Standards 1.2 Description of PCI Data Standard structure 1.3 Source documents used to develop the PCI Data Standards 1.4 Priority ratings 1.5 Description of the PCI Data Standard structure – sections 1.6 Description of registers and databases 1.7 PCI data standards

CARDS PCI Expert Committee PCI Data Standards 1.1 Description of PCI data standards
These are data standards for recording data on percutaneous coronary intervention [PCI] procedures. 1.2 Description of the PCI Data Standards structure
The data standards are set out under headings, as follows: 1. Field ID Number – each data field has an identification number. Data items that are common to the three modules [CCU/ACS, PCI and EP] have the
same Field ID Number
2. Field name – this is a prompt or title for the field that could be used on a data entry form or screen, for example date of birth.
3 & 4. Field content – the field may have options. These contain two types of items for coding. It contains a short numerical code for classification and also
a short string, again identifying a classification. For example the data field Sex he options (1) Male, (2) Female and (9) Unknown, the numerical codes are
(1), (2) and (9) and the short string includes male, female and unknown.
5. Definition of field – This is a description/explanation of the field name.
6. Definition of field options - This is a definition of the field content
7. Data format – this identifies the field's format. Example of formats include date, date and time, numeric, text single value and text multiple values. The
classification used can be seen in appendix 2.
1.3 Source documents used to develop the PCI Data Standards

CARDS PCI Expert Committee PCI Data Standards Source documents included national and international registers and internationally recognised guidelines. Below is a list of the national and international
databases, registers, surveys and guidelines that were used to compile the Percutaneous Coronary Intervention matrix from which the data standards were
derived. A brief description of some of the sources is given in section 1.6.
Databases, Registries and Surveys on Percutaneous Coronary Intervention
The European Coronary Intervention Register Austria's National PTCA database The Spanish Registry of Cardiac Catheter Interventions (SRCCI)
The Swedish Coronary Angiography Angioplasty Registry (SCARR)
The American College of Cardiology Cath lab module v3.0 The British Cardiac Interventional Society's Coronary Angioplasty Register (BCIS)
The Mater Hospital Dublin PCI Register Shakespeare Registry Arbeitsgemeinschaft Leitender Kardiologischer Krankenhausarzte (German PCI Registry) (ALKK)
The Euro Heart Survey on Revascularisation for Ischemic Heart Disease 2001 The Swiss Percutaneous Coronary Intervention Register The Polish PCI Register The Italian Drug Eluting Stent Register (ELISIR)
The BHN Registration Project Guidelines and Reference Guides
European Society of Cardiology (ESC) Guidelines: Management of AMI in patients presenting with ST Elevation (2003)
The National Institute for Clinical Excellence [NICE] Guidelines on Coronary Artery Stents in the treatment of Ischaemic Heart Disease 2000
American College of Cardiology [ACC] and the American Heart Association [AHA] guideline for Percutaneous Coronary Intervention 2001
1.4 Priority Ratings
Priority rating refers to the overall importance of the variable to be collected in relation to the following objectives: - CARDS PCI Expert Committee PCI Data Standards Service planning and funding agencies x Epidemiological research Variables to be collected are to be considered under three priority groupings, viz. High - these variables will be of prime importance in relation to the above objectives
NB - the variables in this group would be essential components of a minimum core data set and include variables without which the data would be considered useless,
e.g. sex, age, diagnosis. These variables include those, which would be essential in order to link up with other cardiovascular disease surveillance datasets.
Medium – these would help build up a complete picture of the patient but would not necessarily alter the definitive care of the patient.
Low – these are variables that do not impact on patient care during the PCI or in hospital prior to discharge. Again they would help complete the information in relation to
the event leading to admission. However, they may in the future be available from other cardiac disease information surveillance modalities, e.g. cardiac rehabilitation,
general practitioner (GP) surveys. Also these variables would be considered of least importance in meeting the objectives of collecting the data.
NOTE: All data items are seen as high priority unless otherwise stated. Data items deemed as medium priority are marked MP and low priority data items are marked asLP in the field ID number.
1.5 Description of the PCI Data Standards structure - sections
The data standards is subdivided into the following sections: Demographics: the demographic section contains data fields such as date of birth, and sex.
History [relevant to Coronary Artery Disease, CAD]: includes data on the patient's previous medical history such as, previous myocardial
infarction, and also includes data fields for previous tests, interventions and procedures such as, percutaneous coronary interventions (PCI), and
coronary artery bypass graft (CABG).
Risk factors [relevant to Coronary Artery Disease, CAD]: the risk factor section contains data fields for current risk factors relating to CAD, for
example smoking, hypertension and hyperlipidemia.
CARDS PCI Expert Committee PCI Data Standards Investigations for Coronary Artery Disease: this includes data on investigation that the patient underwent before PCI, examples include: - stress
test, angiogram, echocardiogram, and holter monitor.
Percutaneous Coronary Intervention: This subsection focuses on revascularisation by PCI.
Medication during PCI: this subsection collects data on the medication that was administered during this hospital stay, both in relation to coronary
artery disease status and PCI.
Outcome: this captures data on the immediate outcome after the PCI.
For example did the patient experience a stroke, a major bleed, or did the patient have any serious complications as a result of the PCI. Medication: discharge: includes data items on medication at discharge from hospital.
Follow up: it is proposed to collect information at 30 days and 12 months after the index event. This section captures information on whether the
patient is dead /alive at the time of follow- up. This section also captures data on readmission to hospital, major adverse cardiac events and
medication at follow up
1.4 Description of registers and databases
The following is a description of some national and international databases, registers and surveys used as data sources to develop the PCI data standards.
A brief description is given for each of these under the headings; - devised by, type, details on data set and coverage.
The European Percutaneous Coronary Intervention Register
Devised by: The Working Group on Coronary Circulation of the European Society of Cardiology [ESC].
Type: This is an annual paper based survey that is supported by the national societies of cardiology in each of the participating countries. Co-ordinators in
European countries collect data retrospectively.
CARDS PCI Expert Committee PCI Data Standards Details on the data set: Collects numerical data and comments on coronary angiography, angioplasty, and stenting, other new devices, non- coronary
cardiac interventions and catheterisation facilities performed in the respective year.
There are 48 data variables in total:
1. Data on institution and country (8 variables)2. PCI data (30 variables)3. Other data including VSD, ASD, and PFA closure by catheter (8 variables) Coverage: 25 countries that are members of the European Society of Cardiology
Austria's National Percutaneous Transluminal Coronary Angioplasty (PTCA) database (1992- 2003)
Devised by: The Working Group of the Austrian Society of Cardiology on Interventional Cardiology.
Type: This is a computer-based system and a wide area network links all centres. It collects data for audit, quality control and quality management
Details on data set: 40-48 variables are similar to those of the European PCI Register. Additional data on PTCA is collected.
Coverage: National in scope, It covers 34 adult catheter laboratories centres and 4 paediatric centres.
Spanish Registry of Cardiac Catheter Interventions (SRCCI)
Devised by: the Spanish Society of Cardiology.
Type: It is a paper-based questionnaire.
Details on data set: Variables are the same as the European PCI Register and additional data on non-cardiovascular interventions such as, mitral
valvuloplasty cases, aortic valvuloplasty and pulmonary valvuloplasty are collected. It collects data on the following; geographic, diagnostic procedures,
interventional procedures, interventional procedures in acute myocardial infarction, use of other devices and coronary procedures and non-coronary
cardiovascular interventions.
Coverage: It collects data from 101 catheter laboratories in Spain.
Swedish Coronary Angiography and Angioplasty Registry (SCAAR)
CARDS PCI Expert Committee PCI Data Standards Devised by: At the end of 1998 the National Registry for Coronary Angiography and the Swedish Registry for Coronary Angioplasty (SCAP) was merged into
a single registry, SCAAR. Stockholm County Council is responsible for the registry. The purpose of this registry is to provide a description of patients who
have undergone coronary angiography at one of the 28 different units in the country.
Type: This is a computer-based system; it collects data on all patients undergoing coronary angiographies or PTCA in Swedish hospitals. At a local level the
nurses and physicians fill in all data at the time of procedure. Data were sent yearly to the national database by diskette or email, but the system is now
Internet based, with interactive capabilities.
Details on data set: Registration includes background factors such as age sex, risk factors, function group, procedure data, and complications during and
after investigations/treatment, primary decision after angiography and the primary result after intervention.
Coverage: Data are collected from 16 (68%) of the 28 units where coronary angiographies are performed and all 12 (100%) PTCA centres participate
American College of Cardiology (ACC) Cath Lab Module v3.0
Devised by: The American College of Cardiology provides a service, for a fee (approx $2000). An institution can send data to the ACC and in return the
ACC sends that institution annual reports. This is part of the National Cardiovascular Data Registry (ACC- NDCR).
Type: This a confidential quality measurement programme for cardiovascular specialists, hospitals, and catheterisation laboratories. The ACC provides
comparison of the participant's practice patterns and outcomes to national and peer data group. Participants use this information for improving patient care,
supporting local quality-improvement programmes, and communicating with regulatory and contracting organisations. The ACC certifies software vendors,
insuring the data that are submitted are of the required quality.
Details on data set: The register collects the following data:
Cardiac status—measurement of acute coronary syndrome time period, angina type, and non-invasive testing Adverse outcomes—Periprocedural MI and CK-MB levels, contrast reactions Performance measures—door to balloon/stent time Optional follow-up—6-month vital status (alive, expired, primary cause of death, readmission, readmission reason. Coverage: The programme is multicentered, voluntary and national in scope.
CARDS PCI Expert Committee PCI Data Standards British Cardiac Interventional Society Coronary Angioplasty Register (BCIS v5.1.2)
Devised by: This was devised and approved by The British Cardiac Interventional Society (BCIS) and the Central Cardiac Audit Database (CCAD) in 2003.
Type: Patients undergoing Percutaneous Coronary Intervention in the UK. This is a computer-based system and encrypted data are transmitted to a central
database - the Central Cardiac Audit Database (CCAD).
Details on data set: Data are collected on the following; structure, appropriateness of the procedure, process/procedure and outcome of the procedure.
Coverage: 63 of the 64 centres provide data in the UK. However not all 63 centres provide the required completeness of quality data
The Mater Hospital Dublin Percutaneous Cardiovascular Interventional Register
Devised by: The Mater Cardiovascular Research Group devised this register in conjunction with DMF systems.
Type: Patients admitted to the Mater Public and Private hospitals that have undergone a percutaneous coronary intervention are included. This is a
computer-based system that has been written in Microsoft Access TM.
Details on data set: Data collected includes demographic details, clinical status and investigations, procedures, immediate follow-up, long-term follow-up and
quality of life.
Coverage: Data are collected from the Mater Public and Private Hospitals in Dublin, Ireland.
Devised by: This European register is sponsored by the pharmaceutical industry.
Details on the data set: Data are collected on the following: baseline data, PCI data, follow-up after 30 days, follow-up after one-year.
Coverage: The following countries participate: UK, Germany, France, Italy, Portugal, Israel and Poland.
CARDS PCI Expert Committee PCI Data Standards The ‘Arbeitsgemeinschaft Leitender Kardiologischer Kranken-hausaertzte' in Germany (ALKK)
Devised by: The registry was devised by ALKK (The ‘Arbeitsgemeinschaft Leitender Kardiologischer Kranken-hausaertzte' in Germany) in 1992.
Type: This is a computer-based system where data are collected on PTCA (>200,000 patients), on direct angioplasty in acute myocardial infarction (ca. 5000
patients), on coronary stenting (>50,000 patients), and on carotid stenting.
Details on the data set: The register includes data on baseline characteristics, the indication for the procedure, the immediate outcome for the procedure,
and the in-hospital course.
Coverage: This registry collects core data on all patients undergoing a percutaneous coronary intervention in 86 participating German centres.
The Euro Heart Survey on Revascularisation for Ischaemic Heart Disease 2001
Devised by: the Scientific Expert Committee for Euro Heart Revascularisation within the European Society of Cardiology devised this survey in 2000. The
data were collected between September 2001 and January 2002.
Type: each country has a national co-ordinator (a national authority in cardiology) who represents the Euro Heart Survey at national level and helps to select
appropriate hospitals for the survey. The data are collected over a 1-4 month period by qualified DCOs (Data Collection Officers) and entered on-site in an
electronic database. The content of the database is then transferred to the Euro Heart Survey Department at the Heart House (in Sophia Antipolis, France)
via the Internet where it is submitted to a quality data check. When the data has successfully passed this procedure it is considered to be final and ready for
analysis.
Details on data set: Angiography, PCI and CABG are the main topics in this survey, but data are also collected on the hospital facilities, risk factors,
immediate outcome and one-year clinical outcome.
Coverage: 25 countries: Austria, Belgium, Czech Republic, Denmark, Finland, France, Germany, Georgia, Greece, Hungary, Ireland, Israel, Italy, Lithuania,
the Netherlands, Poland, Portugal, Russia, Slovenia, Slovakia, Sweden, Switzerland, Turkey and UK.
Swiss Percutaneous Coronary Intervention Register
Devised by: the Swiss Society of Cardiology devised this register in 1987.
CARDS PCI Expert Committee PCI Data Standards Type: This is a yearly questionnaire.
Details on data set: It is based on a standardised questionnaire that includes the minimal data set of the European Register of Coronary Catheter
Interventions. Some quality control of the gathered data was assured by submitting a non-blinded summary to all involved cardiac catheterisation laboratories
for corrections before open publication of individualised data in a Swiss medical journal once a year
Coverage: 25 institutions in Switzerland are involved (5 university hospitals, 10 public hospitals and 10 private hospitals).
The Italian Drug Eluting Stent Registry (ELISIR)
Devised by: the Italian Society of Cardiology.
Type: The enrollment of patients started on October 2002. The purpose of this registry was to verify the effective use of drug eluting stent (DES) in the 162
Italian cath labs and to evaluate if the indications are different/similar to that of other countries. Data about Italian patients who underwent PCI with DES
implantation were collected by a computer-based system. Information is written on the electronic web page of the Italian Society of Invasive Cardiology,
named GISE.
Details on data set: Registration included background factors such as age sex, risk factors, function group, procedure data, and complications during and
after investigations/treatment, type of DES deployed (diameter, length, apposition etc) and the primary result after intervention.
Coverage: Forty-nine (49) Italian catheterisation laboratories participated in this registry and 2262 patients were enrolled from November the 1st 2002 to
October the 12th 2003.
CARDS PCI Expert Committee PCI Data Standards PCI Data Standards
Short Field content
Definition of Field
Definition of field options
PCI 1.01 Hospital identification number Indicate the hospital identification number PCI 1.02 Patient identification number Indicate the patient identification number PCI 1.03 Date of birth The date the patient was born as recorded on their birth certificate The sex of the patient Information missing PCI 1.07 Transferred from another Indicate if the patient was transferred from another hospital for this admission Past History relevant to Coronary Artery Disease - Previous history may be documented in the patient's medical notes, GP letter or other referral letters or the patient or the patient's family may have
positive information from medical professionals that confirm history.
PCI 2.01 History of previous myocardial Indicate if the patient has had at least one previous Patient has no history of a previous myocardial infarction.
myocardial infarction before this admission.
Patient has had at least one myocardial infarction previously Information missing PCI 2.03 History of congestive heart Indicate if the patient has a history and/or has Patient has no previous history of congestive heart failure.
previously been treated for congestive heart failure Patient has a history of congestive heart failure.
Information missing PCI 2.04 History of stroke Indicate if the patient has a history of cerebrovascular Patient has no previous history of stroke accident / stroke, as evidenced by persistent Patient has a history of stroke neurological deficit due to ischaemia. Information missing Last updated on the 2nd of November CARDS PCI Expert Committee PCI Data Standards Short Field content
Definition of Field
Definition of field options
PCI 2.05 History of History or evidence of aneurysm or occlusive Patient has no previous history of peripheral vascular disease Code n2 peripheral vascular disease peripheral vascular disease or carotid disease, including aortic aneurysm, previous aorto-iliac or The patient has a history of peripheral vascular disease peripheral vascular surgery, or reduced or absent Information missing peripheral pulses and / or angiographic stenosis of more than 50%. PCI 2.06 History of chronic renal failure Indicate if the patient has a history of chronic renal The patient has no previous history of chronic renal failure failure documented by any one of the following: The patient has a history of chronic renal failure.
(a) Serum creatinine greater than 2.0 mg/dl or 200
Information missing umol/l in the past
(b) On dialysis
(c) Has had a renal transplantation
PCI 2.08 Previous percutaneous Indicate if the patient has had a previous PCI of any The patient has never had a previous percutaneous coronary Code n2 coronary intervention (PCI) type before the current admission (e.g. balloon angioplasty, implantation of intra coronary The patient has had a previous percutaneous coronary stent or other catheter devices for treating coronary intervention prior to this admission atheroma, atherectomy, laser angioplasty or other). Information missing Coronary artery bypass graft Indicate if the patient had a coronary artery bypass The patient has never had a previous CABG graft (CABG) done prior to this admission The patient has had a previous CABG prior to this admission Information missing History of valvular heart Indicate if the patient has a history of haemodynamically significant valvular heart disease or prior valvular heart surgery/replacement/intervention Information missing Last updated on the 2nd of November CARDS PCI Expert Committee PCI Data Standards Short Field content
Definition of Field
Definition of field options
Risk Factors for Coronary Artery Disease
PCI 3.01 Smoking status Indicate if the patient has a history confirming any form Patient has never smoked a tobacco product of tobacco use in the past. This includes cigarettes, Patient regularly smokes a tobacco product / products one or cigar and/or pipe more times per day or has smoked in the 30 days prior to this admission Patient has stopped smoking tobacco products greater than 30 days before this admission Information missing PCI 3.02 Diabetes mellitus Indicate if the patient has a history of diabetes mellitus Patient does not have diabetes Diabetic (dietary control) diagnosed prior to the current admission The patient has received dietary advice appropriate to their condition but is not receiving medication Diabetic (oral medication) The patient uses oral medication to control their condition Diabetic (insulin) The patient uses insulin treatment, with or without oral therapy, to control their condition Newly diagnosed diabetic If a patient is admitted with new (not previously diagnosed) diabetes use option "newly diagnosed diabetes" as final treatment modality will not be known Information missing PCI 3.03 History of hypertension Indicate if the patient has a history of hypertension The patient does not have a history of hypertension prior to diagnosed and/or treated by a physician The patient does have a history of hypertension prior to this admission Information missing PCI 3.03 History of Indicate if the patient has a documented history of The patient does not have a history of hypercholesterolemia hypercholesterolemia diagnosed and/or treated by a prior to this hospital admission The patient does have a history of hypercholesterolemia prior to this admission Information missing Last updated on the 2nd of November CARDS PCI Expert Committee PCI Data Standards Short Field content
Definition of Field
Definition of field options
Admission Details and Initial Assessment
PCI 5.01 Indication for percutaneous STEMI / primary PCI Indicate the reason why the percutaneous coronary coronary intervention [PCI] STEMI / rescue PCI intervention was performed.
STEMI / facilitated PCI NSTEMI (ongoing instability) Unstable angina (ongoing instability) Post STEMI (stabilised) Post NSTEMI (stabilised) Post unstable angina (stabilised) Elective PCI (stable angina and / or documented ischaemia) Information missing PCI 5.02 Symptom onset date and time Indicate the time of symptom onset that triggered the decision for PCI.
(e.g. if a patient making uncomplicated recovery from STEMI treated by lysis develops recurrent pain requiring PCI at for example day 4, then day 4 is the time recorded).
PCI 5.03 Date and time of Date/time of admission to first hospital (potentially of a admission/arrival at hospital series of hospitals) where cardiological treatment (for ACS patients) initiated (i.e. not necessarily the hospital where PCI is performed) PCI 5.04 Elevated biochemical marker Indicate if the patient's biochemical markers [Troponin The patient's biochemical markers were not raised above the Code n2 T/I ,CK-MB and/or CK] were raised above the levels levels recognised in guidelines for diagnosis of acute recognised in guidelines for diagnosis of acute myocardial infarction myocardial infarction pre-procedure. The patient's biochemical markers were raised above the (NB these levels may vary between laboratories) levels recognised in guidelines for diagnosis of acute myocardial infarction Information missing Last updated on the 2nd of November CARDS PCI Expert Committee PCI Data Standards Short Field content
Definition of Field
Definition of field options
PCI 5.05 Date and time of percutaneous Indicate the date and time the PCI was performed coronary intervention [PCI] PCI 5.06 Cardiogenic shock at start of Indicate if the patient presented with cardiogenic shock before the PCI procedures requiring inotropes, intra-aortic balloon pump or CPS to support circulation PCI 5.07 Haemodynamic support Indicate if haemodynamic support was needed before The patient did not require haemodynamic support before the Code n2the start of the PCI procedure start of the PCI procedure Yes (IABP/ CP bypass) The patient did require haemodynamic support, either an intra-aortic balloon pump or cardio-pulmonary bypass before the start of the PCI procedure Information missing Investigations for Coronary Artery Disease
PCI 6.01 Left ventricular (LV) function Indicate the patients estimated or calculated left Slightly reduced (41-50%) ventricular [LV] function This categorises the percentage of the blood emptied from the left ventricle at the end of the contraction. Data may have been Moderately reduced (31- derived form angiography, echocardiography, nuclear imaging, magnetic resonance imaging etc.
Severely reduced (<30%) Angiogram Result (see appendix 5 for diagram of coronary arteries) PCI 6.02 Proximal right coronary artery Indicate the percentage stenosis (0-100%) conduit (pRCA) [Segment No
1]
PCI 6.03 Mid-right coronary artery Indicate the percentage stenosis (0-100%) conduit (mRCA) [Segment No
2]
PCI 6.04 Distal right coronary artery Indicate the percentage stenosis (0-100%) conduit (dRCA) [Segment No
3]
PCI 6.05 Right posterior descending Indicate the percentage stenosis (0-100%) artery (rPDA) [Segment No 4]
Last updated on the 2nd of November CARDS PCI Expert Committee PCI Data Standards Short Field content
Definition of Field
Definition of field options
PCI 6.06 Left main coronary artery (LM) Indicate the percentage stenosis (0-100%) [Segment No 5]
PCI 6.07 Proximal LAD artery (pLAD) Indicate the percentage stenosis (0-100%) [Segment No 6]
PCI 6.08 Mid-LAD artery (mLAD) Indicate the percentage stenosis (0-100%) [Segment No 7 ]
PCI 6.09 Distal LAD artery (dLAD) Indicate the percentage stenosis (0-100%) [Segment No 8]
PCI 6.10 First diagonal branch (1st Indicate the percentage stenosis (0-100%) Diag)
[Segment No 9]
PCI 6.11 Second diagonal branch (2nd Indicate the percentage stenosis (0-100%) Diag) [Segment No 10]
PCI 6.12 Proximal circumflex coronary Indicate the percentage stenosis (0-100%) (pCIRC)
[Segment No 11]
PCI 6.13 First obtuse marginal branch Indicate the percentage stenosis (0-100%) (1st OM)
[Segment No 12]
PCI 6.14 Mid Circumflex artery (CIRC) Indicate the percentage stenosis (0-100%) [Segment No 13]
PCI 6.15 Other obtuse segments Indicate the percentage stenosis (0-100%). Other obtuse segments include: Lateral first obtuse marginal branch segment, Second obtuse marginal branch segment, Lateral second obtuse marginal branch segment, Third obtuse marginal branch segment,and the Lateral third obtuse marginal branch segment.
PCI 6.16 Right posterolateral segment Indicate the percentage stenosis (0-100%). This includes the following: First right posterolateral segment, Second right posterolateral segment and the Third right posterolateral segment.
PCI 6.17 Left main stem protected Indicate whether the Left Main lesion attempted was protected - defined as a patent graft to either LAD or LCX Last updated on the 2nd of November CARDS PCI Expert Committee PCI Data Standards Short Field content
Definition of Field
Definition of field options
Percutaneous Coronary Intervention (see table appendix 4 )
Indicate for the treated segment the segment number [1-15] (See the angiogram detail above for segment number and diagram in appendix 4) NOTE:
If PCI is to a lesion in an arterial bypass graft the
segment number is denoted by segment number to
which arterial graft is attached PLUS 200, e.g if PCI
is to a graft to the proximal LAD segment (pLAD)
then the segment number = 5+ 200 i.e. 205
If PCI is to a lesion in a venous bypass graft the
segment number is denoted by segment number to
which venous graft is attached PLUS 300, e.g if PCI
is to a graft to the proximal LAD segment (pLAD)
then the segment number = 5 + 300 i.e.305
Last updated on the 2nd of November CARDS PCI Expert Committee PCI Data Standards Short Field content
Definition of Field
Definition of field options
Indicate the type of lesion -Discrete (<10 mm length)-Concentric-Readily accessible-Non-angulated segment, <45-Smooth contour-Little or no calcium-Less than totally occlusive-Not ostial in location-No major side branch involvement-Absence of thrombus Type B-Tubular (10-20 mm length)-Eccentric-Moderate tortuosity of proximal segment, >= 45, <90-Irregular contour-Moderate to heavy circulation-Total occlusion <3 months old-Ostial location-Bifurcation lesion requiring double guidewire-Some thrombus present Type C-Diffuse (>=20 mm length)-Excessive tortuosity of proximal segment-Extremely angulated segments, >=90-Total occlusion >3months old-Inability to protect major side branches-Degenerated side branches with friable lesions Information missing In-stent re-stenosis Indicate for the treated segment if there is in-stent re- No in-stent re-stenosis in the treated segment There is in-stent re-stenosis in the treated segment Information missing Last updated on the 2nd of November CARDS PCI Expert Committee PCI Data Standards Short Field content
Definition of Field
Definition of field options
Indicate if the lesion is at a bifurcation.
The lesion is not at a bifurcation The lesion is at a bifurcation A bifurcation is a division of a vessel into at least two Information missing branches, each of which is 2mm or greater in diameter. In a bifurcation the plaque extends on both sides of the bifurcation point. It need not progress down both branches, each of which is >2mm or greater [ACC] TIMI flow before PCI Indicate for the segment identified the pre-PCI TIMI No flow/ no perfusion.
Slow penetration without perfusion.
Partial flow/partial perfusion (greater than TIMI-1 but less than TIMI-3).
Complete and brisk flow/complete perfusion Information missing TIMI flow after PCI Indicate for the segment identified the post-PCI TIMI No flow/ no perfusion.
Slow penetration without perfusion.
Partial flow/partial perfusion (greater than TIMI-1 but less than TIMI-3).
Complete and brisk flow/complete perfusion Information missing % Stenosis before PCI Indicate for the treated segment the pre-PCI percent % Stenosis after PCI Indicate for the treated segment the post- PCI percent Indicate for the treated segment if a stent was used Information missing Indicate for the treated segment if direct stenting was carried out, I.e. direct stent placement without balloon predilatation of the target lesion Information missing Indicate for the treated segment the stent type Information missing Last updated on the 2nd of November CARDS PCI Expert Committee PCI Data Standards Short Field content
Definition of Field
Definition of field options
Drug-eluting type Indicate the drug-eluting type Trial drug eluting stent Information missing Stent/balloon size Indicate for the treated segment the largest [maximum] vessel diameter or the largest [maximum] device diameter (balloon or stent) in millimetres Indicate the longest stented segment (or balloon if no stents) in millimetres used during the intervention.
Add the length of all contiguous stents Percutaneous Coronary Intervention (other details)
Percutaneous arterial access Indicate the primary location of percutaneous arterial Femoral-Percutaneous puncture of either femoral artery Brachial-Either a cutdown or percutaneous puncture of either brachial artery.
Radial-Percutaneous radial approach.
Other-Percutaneous entry other than femoral, brachial, or radial approaches to the cardiovascular system.
Information missing Diagnostic device used during Indicate diagnostic device (s) was used during this Intravenous ultra sound Intracoronary Doppler Information missing Last updated on the 2nd of November CARDS PCI Expert Committee PCI Data Standards Short Field content
Definition of Field
Definition of field options
Therapeutic devices used Indicate for the treated segment the intracoronary device(s) used. Tick in chronological order.
Distal Protection Device Direct Coronary Artretomy Vascular brachytherapy Information missing No peri-procedural Indicate the peri-procedural complications Acute segment closure Side branch occlusion Coronary perforation No flow/slow flow phenomenon Heart block requiring pacing Shock induced by procedure Allergic reactions Information missing Coronary artery bypass graft Indicate if the patient underwent a CABG The patient did not undergo a CABG The patient underwent an emergency CABG immediately post the PCI procedure A decision has been made to perform a CABG in the future (non emergency) Information missing Vascular closure device Indicate if a vascular closure device for percutaneous arterial management was used during or after this PCI procedure Information missing Last updated on the 2nd of November CARDS PCI Expert Committee PCI Data Standards Short Field content
Definition of Field
Definition of field options
Percutaneous arterial Indicate if there were arterial percutaneous complicationspost PCI procedure.
Haemorrhage requiring surgery or transfusion Note: Some of these complications occur immediately Arterial occlusion/dissection after the PCI procedure, while others will occur later requiring intervention during hospital stay.
Information missing Medication at the time of PCI
Indicate whether the patient was on aspirin at the time The patient was not taking aspirin at the time of PCI The patient was taking aspirin at the time of PCI Information missing PCI 7.02 Other antiplatelet Indicate if the patient was given antiplatelet (other than Antiplatelet medication was not administered at the time of aspirin) medication at the time of PCI Clopidogrel/Ticlopidine was administered at the time of PCI Other antiplatelet agent Other antiplatelet agent(s) was administered at the time of PCI (other than apsirin/clopidogrel/ticlopidine) Information missing PCI 7.03 Anticoagulants Indicate if the patient was given anticoagulant Anticoagulants were not administered at the time of PCI medication at the time of PCI Vit. K antagonists Vitamin K antagonists [e.g. warfarin, coumadin, other etc] were administered at the time of PCI Oral thrombin inhibitors Other thrombin agents [e.g. ximelagatran] were administered at the time of PCI Other anticoagulants agents Other anticoagulants agents were administered at the time of PCI Information missing PCI 7.04 Glycoprotein IIb/IIIa Indicate the glycoprotein IIb/IIIa type administered at Glycoprotein IIb/IIIa medication was not administered at the the time of PCI procedure Abciximab was administered at the time of PCI Eptifibitide was administered at the time of PCI Tirofiban was administered at the time of PCI Information missing Last updated on the 2nd of November CARDS PCI Expert Committee PCI Data Standards Short Field content
Definition of Field
Definition of field options
PCI 7.05 Heparin/low molecular weight Indicate if heparin and/or LMWH were administered at Unfractionated heparin and/or LMWH were not administered at the time of PCI Unfractionated heparin Unfractionated heparin was administered at the time of PCI LMWH was administered at the time of PCI LMWH + Unfractionated Both unfractionated heparin and LMWH were administered at Information missing PCI 8.04 Elevated biochemical marker Indicate if the patient's biochemical markers [Troponin T/I ,CK-MB and/or CK] were raised above the levels recognised in guidelines for diagnosis of acute Information missing myocardial infarction after the PCI procedure.
(NB these levels may vary between laboratories) PCI 8.01 Myocardial (re)infarction post Indicate if the patient developed a myocardial (re)infarction after the index PCI procedure (other than procedural related increases in cardiac markers) Information missing PCI 8.02 Bleeding during hospital stay Indicate if there was an episode of bleeding during the The patient did not experience a major bleed during hospital hospital stay that required close monitoring and/ or Intracranial bleed specific treatment, e.g. transfusion (blood or blood The patient had an intracranial bleed documented by one of the following:- bleeding in or around the brain Not associated with arterial access site - haemorrhagic conversion of a primary ischaemic stroke- subarachnoid haemorrhage- intracerebral haemorrhage- other (subdural and epidural) Retroperitoneal bleed The patient had a major retroperitonel bleed. Major: Overt clinical bleeding associated with a drop in
haemoglobin of greater than 5 g/dl (0.5g/l) or in haemocrit of
15% (absolute)
Any other spontaneous The patient had a major spontaneous bleed at other site Major: Overt clinical bleeding associated with a drop in
haemoglobin of greater than 5 g/dl (0.5g/l) or in haemocrit of
15% (absolute)
Information missing Last updated on the 2nd of November CARDS PCI Expert Committee PCI Data Standards Short Field content
Definition of Field
Definition of field options
Indicate if the patient experienced a stroke/cerebrovascular accident (CVA) after the PCI ,as evidenced by persistent loss of neurological Information missing function caused by an ischaemic event.
PCI 8.05 Renal failure requiring dialysis Indicate if renal failure requiring dialysis occurred during this hospital admission Information missing PCI 8.11 Survival status at discharge Indicate vital status at discharge Information missing PCI 8.12 Date of discharge/death Indicate the date the patient was discharged from hospital or if patient died record the date of death PCI 8.13 Discharge destination Indicate the patient discharge destination Transferred to other hospital Information missing Medication at discharge
Indicate if the patient was prescribed aspirin on The patient was not prescribed aspirin on discharge from discharge from hospital The patient was prescribed aspirin on discharge from hospital Information missing PCI 9.02 Other antiplatelet Indicate if the patient was prescribed antiplatelet The patient was not prescribed antiplatelet on discharge from Code n2 medication (other than aspirin) on discharge from The patient was prescribed clopidogrel/ticlopidine on discharge from hospital Other antiplatelet agent The patient was prescribed other antiplatelet agents on discharge (other than apsirin/clopidogrel/ticlopidine) Information missing Last updated on the 2nd of November CARDS PCI Expert Committee PCI Data Standards Short Field content
Definition of Field
Definition of field options
PCI 9.03 Anticoagulants Indicate if the patient was prescribed anticoagulant The patient was not prescribed anticoagulant medication on medication on discharge from hospital.
discharge from hospital Vit. K antagonists The patient was prescribed vitamin K antagonists [warfarin, coumadin, etc] on discharge from hospital Oral thrombin inhibitors The patient was prescribed thrombin inhibitors [e.g. ximelagatran] on discharge from hospital The patient was prescribed other anticoagulants on discharge from hospital Information missing PCI 9.04 Beta-blockers Indicate if the patient was prescribed Beta-Blockers on The patient was not prescribed Beta-blockers on discharge discharge from hospital The patient was prescribed Beta-blockers on discharge from hospital Information missing PCI 9.05 ACE inhibitors Indicate if the patient was prescribed ACE inhibitors on The patient was not prescribed ACE inhibitors on discharge discharge from hospital The patient was prescribed ACE inhibitors on discharge from hospital Information missing PCI 9.06 Angiotensin II receptor Indicate if the patient was prescribed angiotensin II The patient was not prescribed angiotensin II receptor receptor blockers on discharge from hospital blockers on discharge from hospital The patient was prescribed angiotensin II receptor blockers on discharge from hospital Information missing PCI 9.07 Diabetic control Indicate the main method of diabetic treatment the
On discharge the patient was not currently on diet, oral agent Code n2 patient was prescribed on discharge from hospital and/or insulin for his/her diabetes Insulin and oral agent On discharge the main method of diabetic control was a
combination of insulin and oral agent
On discharge the main method of diabetic control was insulin
On discharge the main method of diabetic control was oral
agent
On discharge the main method of diabetic control was diet
alone
Information missing Last updated on the 2nd of November CARDS PCI Expert Committee PCI Data Standards Short Field content
Definition of Field
Definition of field options
Indicate if the patient was prescribed statins on The patient was not prescribed statins on discharge from discharge from hospital The patient was prescribed statins on discharge from hospital Information missing PCI 9.09 Non-statin lipid lowering Indicate if the patient was prescribed non-statin lipid The patient was not prescribed any non-statin lipid lowering lowering agents on discharge from hospital agent on discharge from hospital The patient was prescribed ezetimibe on discharge from hospital The patient was prescribed fibrates on discharge from hospital The patient was prescribed other non-statin lipid lowering agent on discharge from hospital Information missing PCI 9.10 Glycoprotein IIb/IIIa Indicate the use of Glycoprotein IIb/IIIa inhibitors on The patient was not prescribed glycoprotein IIb/IIIa on discharge from hospital discharge from hospital The patient was prescribed abciximab on discharge from hospital The patient was prescribed eptifibitide on discharge from hospital The patient was prescribed tirofiban on discharge from hospital Information missing PCI 9.11 HeparinlLow molecular weight Indicate if the patient was prescribed unfractionated Unfractionated heparin and/or LMWH were not prescribed on Code n2 heparin/LMWH on discharge.
Unfractionated heparin Unfractionated heparin was prescribed on discharge LMWH was prescribed on discharge LMWH + Unfractionated Both unfractionated heparin and LMWH were prescribed on Information missing Follow Up (30 days and 12months) Date and status at 30 days and 12 months after the index event obtained by any reliable source (outpatient visit, medical record, telephone call, administrative
database
Date of follow up Indicate the date of last follow up alive. This may be the date of follow up or the date the patient is last seen alive by verifiable sources Last updated on the 2nd of November CARDS PCI Expert Committee PCI Data Standards Short Field content
Definition of Field
Definition of field options
Survival status at follow up Indicate vital status at follow up Information missing If the patient died indicate the date of death Primary cause of death Indicate the primary cause of death Cardiovascular death indicates cause of death was sudden cardiac death, MI, unstable angina, or other CAD; vascular death (e.g. stroke, arterial embolism, pulmonary embolism, ruptured aortic aneurysm, or dissection); CHF: or cardiac arrhythmia, consider further specification such as - MI- Ischaemic stroke- Primary arrhythmic death (without MI)- Progressive heart failure- Haemorrhage- related death- Unexplained sudden death Non - Cardiovascular Others causes -e.g. malignancy Information missing Indicate the patients anginal status at the time of follow-up using the Canadian Cardiovascular Society Ordinary physical activity, such as walking and climbing (CCS) grading system stairs, does not cause angina. Angina occurs with strenuous, or rapid, or prolonged exertion at work or recreation. Slightly limitation of ordinary activity. Angina occurs on NB There are eight blocks to a mile walking or climbing stairs rapidly, walking uphill, walking or climbing stairs after meals, in cold, in wind, or when under emotional stress, or during the few hours after awakening. Angina occurs on walking more than 2 blocks (400 metres) and on level terrain and climbing more than one flight of ordinary stairs at a normal pace and under normal conditions. Marked limitation of ordinary physical activity. Angina occurson walking one to two blocks (200- 400 metres) on level terrain and /or climbing more than one flight under normal conditions and at normal pace Inability to carry on any physical activity without discomfort. Anginal syndrome may be present at rest. Last updated on the 2nd of November CARDS PCI Expert Committee PCI Data Standards Short Field content
Definition of Field
Definition of field options
Information missing Grade breathing status using the New York Heart No limitation of physical activity. Ordinary physical activity Association(NYHA) functional classification does not cause undue fatigue, or dyspnoea.
Slight limitation of physical activity. Comfortable at rest, but ordinary physical activity results in fatigue, or dyspnoea Marked limitation of physical activity. Comfortable at rest, but less than ordinary activity causes fatigue, or dyspnoea Unable to carry on any physical activity without symptoms.
Symptoms are present even at rest. If any physical activity is undertaken, symptoms are increased.
Information missing Date of first hospital If the patient is readmitted to hospital indicate the date readmission since discharge Myocardial infarction [MI] Indicate if the patient was diagnosed as having an MI Myocardial Infarction [MI] date Indicate the date the patient had the myocardial Indicate if the patient was diagnosed as having a stroke since discharge,as evidenced by persistent loss of neurological function caused by an ischaemic event.
Indicate the date of stroke Percutaneous coronary Indicate if the patient had a percutaneous coronary intervention [PCI] intervention since the date of discharge Percutaneous coronary Indicate the date of PCI intervention [PCI] date Coronary artery bypass graft Indicate if the patient had a coronary artery bypass graft [CABG] since the date of discharge Last updated on the 2nd of November CARDS PCI Expert Committee PCI Data Standards Short Field content
Definition of Field
Definition of field options
Coronary artery bypass graft Indicate the date of CABG Cardiac rehabilitation program Indicate if the patient attended or is attending a The patient did not or is not presently attending a cardiac cardiac rehabilitation programme since discharge rehabilitation programme [since date of discharge] The patient did or is presently attending a cardiac rehabilitation programme [since date of discharge] Information missing Medication at follow up
On follow up indicate if the patient is taking aspirin The patient is not taking aspirin regularly The patient is taking aspirin regularly Information missing Other antiplatelet On follow-up indicate if the patient is taking antiplatelet The patient is not taking antiplatelet medication regularly medication (other than aspirin) regularly The patient is taking ticlopidine/clopidogrel regularly Other antiplatelet The patient is taking other antiplatelet medication regularly (other than apsirin/clopidogrel/ticlopidine) Information missing On follow-up indicate if the patient is taking The patient is not taking anticoagulants regularly anticoagulant medication regularly Vit. K antagonists The patient is taking vitamin K antagonists [warfarin, coumadin, etc] regularly Oral thrombin inhibitors The patient is taking other thrombin inhibitors [e.g. ximelagatran] regularly The patient is taking other anticoagulant medication regularly.
Information missing On follow-up indicate if the patient is taking Beta- The patient is not taking Beta-blockers regularly.
blockers regularly The patient is taking Beta-blockers regularly.
Information missing On follow-up indicate if the patient is taking ACE The patient is not taking ACE inhibitors regularly.
inhibitors regularly The patient is taking ACE inhibitors regularly.
Information missing Angiotensin II receptor On follow-up indicate if the patient is taking The patient is not taking angiotensin II receptor blockers angiotensin II receptor blockers regularly The patient is taking angiotensin II receptor blockers regularly.
Information missing Last updated on the 2nd of November CARDS PCI Expert Committee PCI Data Standards Short Field content
Definition of Field
Definition of field options
On follow-up indicate the main method of diabetic
The patient is not on diet, oral agent and/or insulin for his/her Code n2 control the patient is regularly receiving Insulin and oral agent The main method of diabetic control is a combination of
insulin and oral agent
The main method of diabetic control is insulin
The main method of diabetic control is an oral agent
The main method of diabetic control is diet only
Information missing On follow-up indicate if the patient is taking statins The patient is not taking statins regularly.
The patient is taking statins regularly.
Information missing Non-statin lipid lowering On follow-up indicate if the patient is non-statin lipid The patient is not taking any non-statin lipid lowering agent lowering agents regularly The patient is taking ezetimibe regularly.
The patient is taking fibrates regularly.
The patient is taking other non-statin lipid lowering agent regularly.
Information missing Last updated on the 2nd of November CARDS PCI Expert Committee PCI Data Standards PCI Draft Data Standards with appendices
Appendix 1
European Society of Cardiology /American College of Cardiology Definition of Myocardial Infarction
Appendix 2
Classification of data format
Appendix 3
Screen shot of PCI table
Appendix 4
Diagram of Coronary Arteries
CARDS PCI Expert Committee PCI Data Standards Appendix 1
European Society of Cardiology /American College of Cardiology Definition of Myocardial Infarction
Reference: Myocardial infarction redefined- a consensus document of the Joint European Society of Cardiology/American College of Cardiology Committeefor the redefinition of myocardial infarction. Euro Heart Journal. 2000;21:1502-1513 (altered) Either one of the following criteria satisfies the diagnosis for an acute, evolving, or recent MI:
1. Typical rise of biochemical markers of myocardial necrosis (troponin or CK-MB) with at least 1 of the following: a. Ischaemic symptomsb. Development of pathological Q waves on the ECGc. ECG changes indicative of ischaemia (ST-segment elevation or depression); for further description see below -ECG changes indicative of myocardial ischemia that may progress to MId. Coronary artery intervention (e.g., coronary angioplasty) 2. Pathological findings of an acute MI ECG changes indicative of myocardial ischaemia that may progress to MI
1. Patients with ST segment elevation: New or presumed new ST segment elevation at the J point in two or more contiguous leads with the cut-off points • 0·2 mV in leads V1, V2, or V3 and • 0·1mV in other leads (contiguity in the frontal plane is defined by the lead sequence aVL, I, inverted aVR, II, aVF, III).
2. Patients without ST segment elevation: a. ST segment depressionb. T wave abnormalities only Criteria for established MI
Any one of the following criteria satisfies the diagnosis for established MI: CARDS PCI Expert Committee PCI Data Standards 1. Development of new pathologic Q wave on serial ECGs. The patient may or may not remember previous symptoms. Biochemical marker of myocardial necrosis may have normalized, depending on the length of time that has passed since the infarct developed.
2. Pathologic finding of a healed or healing MI. CARDS PCI Expert Committee PCI Data Standards Appendix 2 – classification of data format
This column identifies to the supplier the type of storage and the type of processing required for the field. The 'n' indicates the field is numeric. The '1' indicates themaximum length of the value. If 'n1' or 'n2' appears on its own, it will be a numeric value, for example a count. See also 'Code'.
The 'n' indicates the field is numeric. The '3.1' indicates the value may have up to three integer place and one decimal place.
The 'an' indicates the field is alpha numeric. That is, unless otherwise specified, the value may contain any letter, digit or punctuation character. The '7' or '100' indicates the maximumlength of the value. If 'an100' appears on its own, the field is free text The field is a classification field whose permitted values are either defined as part of the dataset The short form is the value listed in the 'Short code' column.
The long form is: Short-code full-stop space Text-for-long-code.
For example, the Short code and Text for long code columns for Gender contain: Any of the following will be accepted CARDS PCI Expert Committee PCI Data Standards The size component of Gender is given as ‘n1', which is the minimum to store the value. Implementers who decide to store the long form within their database would need to make their own determination of the storage requirements.
The majority of codes defined within this dataset will remainunchanged for the life of the dataset. However a small numberof code lists identify devices and drugs and new values may be added The field is an identifier or a code whose permitted values are not defined as part of the dataset or by CCAD. Examples include: NHS Number and GMC number.
The field is a date. [Date (dd/mm/yyyy)] DateTime The field is a date and a time [DateTime (dd/mm/yyyy hh:mm)] Multivalue This modifier can only occur in conjunction with 'Code' or 'Id'.
The addition of ‘Multivalue' to the format means that the codevalue may repeat.
For example: for a field listing previous procedures the codesmight be: 0 None1 Procedure A CARDS PCI Expert Committee PCI Data Standards 2 Procedure B3 Procedure C9 Unknown A patient might have been the subject of none of these procedures, the surgeon might not know the patient's surgicalhistory or the patient might have been the subject of any one, two or all three of the procedures.
For this example field, the maximum number of values is 3 (procedures A, B and C) so implementers would have to determine a method of storing up to three code values in their database. Warning, some multivalue fields are volatile so the maximum number of For the transfer file, a semi-colon delimiters to hold the separatecode values within a single field. For example, if a patient wasthe subject to procedures A and B, the following would be correct values for the field: "1;2""1. Procedure A;2. Procedure B" BCIS v5.12 part of the Central Cardiac Audit Database [United Kingdom]
CARDS PCI Expert Committee PCI Data Standards Appendix 3 - Screen shot of PCI table
CARDS PCI Expert Committee PCI Data Standards Appendix 4 – Diagram of coronary arteries
Segment No 1
Proximal right coronary artery conduit (pRCA) Segment No 2
Mid-right coronary artery conduit (mRCA) Segment No 3
Distal right coronary artery conduit (dRCA) Segment No 4
Posterior descending artery (PDA) Segment No 5
Left main coronary artery (LM) Segment No 6
Proximal LAD artery (pLAD) Segment No 7
Mid-LAD artery (mLAD) Segment No 8
Distal LAD artery (dLAD) Segment No 9
First diagonal branch (1st Diag) Segment No 10
Second diagonal branch (2nd Diag) Segment No 11
Proximal circumflex coronary (pCIRC) Segment No 12
First obtuse marginal branch (1st OM) Segment No 13
Mid Circumflex artery (CIRC) Segment No 14
*Other obtuse segments Segment No 15
**Right posterolateral segment and branches *Segment 14: Other obtuse segments
Lateral first obtuse marginal branch segment
Second obtuse marginal branch segment
Lateral second obtuse marginal branch segment
Third obtuse marginal branch segment
Lateral third obtuse marginal branch segment
**Segment 15: Right posterolateral segment and branches
First right posterolateral segment
Second right posterolateral segment
Third right posterolateral segment
CARDS PCI Expert Committee PCI Data Standards CARDS PCI Expert Committee PCI Data Standards Members of the CARDS Percutaneous Coronary Intervention Expert Committee
Dr. Anselm K. Gitt, (Chair) Department of Cardiology, Oberarzt der Med. Klinik B, Ludwigshafen, Germany Dr. Roger Boyle, National Director for Heart Disease, Department of Health, United Kingdom Ms. Rachel Flynn, Research Officer (Information Systems), Royal College of Surgeons in Ireland, Dublin, Ireland Prof. Ricardo Seabra-Gomes, Hospital Santa Cruz, Instituto do Coracao, Carnaxide, Portugal Dr. José María Hernández, Department of Cardiology, University Hospital Virgin de la Victoria, Malaga, Spain Dr. Ciro Indolfi, Department of Cardiology, Universita degli Studi di Napoli, Napoli, Italy Dr. Peter Ludman, Consultant Cardiologist, Queen Elizabeth Hospital, Birmingham, United Kingdom Prof. Jean Marco, Unité de Cardiologie Interventionnelle, Clinique Pasteur, Toulouse Cedex 3, France Dr. Tage Nilsson, Department of Cardiology, Sahlgrenska University Hospital, Gothenburg, Sweden Dr. Declan Sugrue, Cardiology Department, Mater Private Hospital, Dublin, Ireland Dr. Emer Shelley, National Heart Health Advisor, Department of Health and Children, Dublin, Ireland Prof. Jan G.P. Tijssen, Dept. of Cardiology, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands Prof. Eric Van Belle, Service de Cardiologie B et Hémodynamique, Hôpital Cardiologique, Lille Cedex, France

Source: http://iik.i-med.ac.at/files/2013/Cards_Checklist_2013.pdf